LAS VEGAS (KLAS) — Friday morning, U.S. Department of Health and Human Services (HHS) experts and Sunrise Hospital & Medical Center senior officials discussed the opening of a temporary, physician referral based, center for monoclonal antibody COVID-19 treatments in Las Vegas.
According to Sunrise Hospital, monoclonal antibody treatments are known to decrease the hospitalization rates of people at highest risk for severe disease from COVID-19.
This temporary effort is federally supported by the National Disaster Medical System (NDMS), the third such center in the country.
WATCH NEWS CONFERENCE:
The antibody medicines are administered through an intravenous infusion treatment. The infusion of the therapeutic and medical observation take approximately two-and-a-half hours.
Officials say the COVID surge continues and they expect numbers to continue to rise in the coming weeks.
“In addition to 736 patients at Sunrise Hospital, 207 COVID-19 positive patients are receiving care today. A record volume for the hospital,” says CEO, Todd P. Sklamberg.
Through the clinic, patients can be treated without having to enter the hospital doors, possibly saving that person’s life and preventing overcrowding in the hospital.
With this freestanding clinic, Sunrise Hospital can care for 32 patients a day who have been referred from another emergency room, physician’s office or urgent care center.
The first infusion center opened in El Centro, California, last week and the second opened in Tucson, Arizona, this morning.
- Todd P. Sklamberg, Chief Executive Officer, Sunrise Hospital & Medical Center
- Dr. Steven R. Merta, Chief Medical Officer, Sunrise Hospital & Medical Center (available for Q & A only)
- Dr. John Redd, Chief Medical Officer, HHS Assistant Secretary for Preparedness and Response<
- Lynn Hayes Team Commander, NDMS Disaster Medical Assistance Team, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
The agencies believe this an important tool in the battle against COVID-19. They encourage Nevada providers to take advantage of this expanded capacity and refer eligible patients to be scheduled beginning Friday, January 8.